IXHL

Handel nachbörslich: 2.83 0.01 +0.35%

Incannex Healthcare Inc (IXHL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Incannex Healthcare Inc Stock (IXHL) Company Profile

Incannex Healthcare Inc

Healthcare (1052)

61 409 840 786

8 CENTURY CIRCUIT, NORWEST NSW

Nächster Verdiensttermin

Neueste SEC-Einreichungen

IXHL's Discussions on Twitter

Compare IXHL vs TAK, TEVA, HLN, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IXHL Incannex Healthcare Inc	2.82	35.38M	12,000	-48.41M	-19.99M	-17.18
TAK Takeda Pharmaceutical Co Adr	19.67	62.84B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	41.50	48.40B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	10.13	44.55B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	79.38	32.80B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	533.12	22.87B	3.17B	1.29B	1.01B	27.09

Incannex Healthcare Inc Stock (IXHL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-06-08	Eingeleitet	Alliance Global Partners	Buy

Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten

Finanzdaten der Incannex Healthcare Inc-Aktie (IXHL)

Incannex Healthcare Inc (IXHL)

Incannex Healthcare Inc Stock (IXHL) Company Profile

Compare IXHL vs TAK, TEVA, HLN, ZTS, UTHR

Incannex Healthcare Inc Stock (IXHL) Upgrades & Downgrades

Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten

Medical Marijuana Clinical Trial Landscape Expands as 60+ Leading Companies Accelerate Drug Development | DelveInsight - The Manila Times

Medical Marijuana Clinical Trial Landscape Expands as 60+ Leading Companies Accelerate Drug Development | DelveInsight - GlobeNewswire Inc.

Kairos Pharma, Ltd. (KAPA) Stock Price & News - Syfe

Why Did Incannex (NASDAQ:IXHL) Dose Its First Sleep-Apnea Patient? - Kalkine Media

Incannex begins Phase 2 dosing study for sleep apnea drug By Investing.com - Investing.com South Africa

Incannex begins Phase 2 dosing study for sleep apnea drug By Investing.com - Investing.com Nigeria

$Incannex Healthcare (IXHL.US)$ - Moomoo

Incannex Begins Dosing in Phase 2 Sleep Apnea Trial - minichart.com.sg

Incannex begins Phase 2 dosing study for sleep apnea drug - Investing.com

Incannex begins Phase 2 dosing study for sleep apnea drug By Investing.com - Investing.com Canada

A company with about $70 million in cash and no debt is testing a sleep-apnea treatment. - Stock Titan

IXHLIncannex Healthcare Inc Revenue Breakdown - Finviz

BB: BlackBerry Ltd Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Enterprise value to EBIT forward of Incannex Healthcare Limited – LSX:A2DF4D - TradingView

IXHL Q4'26 Earnings: EPS estimate is (0.14) USD - TradingView

Incannex Healthcare (IXHL) Slides 4.97% to $3.46, Testing Support at $3.29ETF Premium Discount - vinanet.vn

Incannex Healthcare (IXHL) Slides 4.97% to $3.46, Testing Support at $3.29Change of Character - dars.gov.et

What’s Next for Incannex Healthcare (ASX:IHL) After US Patent Win? - Kalkine Media

IXHL Q4'26 Earnings: revenue estimate is 0 USD - TradingView

Incannex doses first patient in sleep apnea drug trial By Investing.com - Investing.com Nigeria

Incannex doses first patient in sleep apnea drug trial - Investing.com India

Incannex (IXHL) Advances Sleep Apnea Drug Trial Amid High Price-to-Sales Valuation - GuruFocus

Incannex Healthcare Doses First Patient in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea - Quiver Quantitative

Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X - Barchart.com

Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X - The Manila Times

Incannex Healthcare (ASX:IHL) Cash Flow Check: What Investors Need to Watch on 19 August - Kalkine Media

Why Is Incannex Healthcare (ASX:IHL) in Market Focus? - Kalkine Media

Incannex Wins US Patent Lift For Sleep Apnoea Pipeline (ASX:IHL) - Kalkine Media

Incannex Healthcare (IXHL) Shows Modest Uptick, Holding Key Support Amid Clinical Pipeline FocusTrend Continuation Trade - vinanet.vn

Incannex Healthcare (IXHL) Climbs 3.8% to $3.28, Testing Key Resistance ZoneMcClellan Summation - vinanet.vn

Incannex Healthcare (IXHL) Climbs 3.8% to $3.28, Testing Key Resistance ZoneGap and Reverse - dars.gov.et

Incannex Healthcare (IXHL) Shows Modest Uptick, Holding Key Support Amid Clinical Pipeline FocusVolatility Skew - dars.gov.et

Polar Asset Management (IXHL) reports 7.0% beneficial stake via 900,000 warrants - Stock Titan

$Incannex Healthcare (IXHL.US)$ - Moomoo

Incannex (ASX:IHL): What Is Changing in the Liquidity Test? - Kalkine Media

Why Does Incannex Healthcare (ASX:IHL) Shape Discipline? - Kalkine Media

Incannex Healthcare (ASX:IHL) Clinical Development Pipeline: Market Outlook - Kalkine Media

Incannex Healthcare Inc. (IXHL) options chain - Yahoo Finance Singapore

Incannex Secures A$5.1M R&D Tax Incentive Refund - theglobeandmail.com

Why Are Incannex Healthcare (ASX:IHL), Cann Group (ASX:CAN), ECS Botanics (ASX:ECS) and Little Green Pharma (ASX:LGP) Back in the Market Spotlight? - Kalkine Media

Why Are BrainChip (ASX:BRN), Incannex Healthcare (ASX:IHL), Lake Resources (ASX:LKE) and Cann Group (ASX:CAN) Back in the Market Spotlight? - Kalkine Media

Incannex receives final A$5.1m R&D tax incentive refund By Investing.com - Investing.com UK

$Incannex Healthcare (IXHL.US)$ - Moomoo

Incannex receives final A$5.1m R&D tax incentive refund By Investing.com - Investing.com Australia

Incannex receives final A$5.1m R&D tax incentive refund - Investing.com

Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026 - The Manila Times

Form 8K Incannex Healthcare Inc. For: 11 August By Investing.com - Investing.com Nigeria

Form 8K Incannex Healthcare Inc. For: 11 August By Investing.com - Investing.com Australia

Form 8K Incannex Healthcare Inc. For: 11 August By Investing.com - Investing.com Canada

Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million in Non-Dilutive Capital Received in 2026 - marketscreener.com

Finanzdaten der Incannex Healthcare Inc-Aktie (IXHL)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie IXHL